BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26774699)

  • 1. [Synovial sarcoma in children and adolescents].
    Mansuy L; Bernier V; Ranchère-Vince D; Mainard L; Orbach D; Corradini N
    Bull Cancer; 2016 Feb; 103(2):210-8. PubMed ID: 26774699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
    Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
    Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
    Kawai A; Woodruff J; Healey JH; Brennan MF; Antonescu CR; Ladanyi M
    N Engl J Med; 1998 Jan; 338(3):153-60. PubMed ID: 9428816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time polymerase chain reaction as an aid for the detection of SYT-SSX1 and SYT-SSX2 transcripts in fresh and archival pediatric synovial sarcoma specimens: report of 25 cases from St. Jude Children's Research Hospital.
    Hill DA; Riedley SE; Patel AR; Shurtleff SA; Hyer J; Cain AM; Billups CA; Downing JR; Pappo AS
    Pediatr Dev Pathol; 2003; 6(1):24-34. PubMed ID: 12469233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.
    Nilsson G; Skytting B; Xie Y; Brodin B; Perfekt R; Mandahl N; Lundeberg J; Uhlén M; Larsson O
    Cancer Res; 1999 Jul; 59(13):3180-4. PubMed ID: 10397263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of molecular and cytogenetic findings in synovial sarcoma.
    Panagopoulos I; Mertens F; Isaksson M; Limon J; Gustafson P; Skytting B; Akerman M; Sciot R; Dal Cin P; Samson I; Iliszko M; Ryoe J; Dêbiec-Rychter M; Szadowska A; Brosjö O; Larsson O; Rydholm A; Mandahl N
    Genes Chromosomes Cancer; 2001 Aug; 31(4):362-72. PubMed ID: 11433527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan.
    Takenaka S; Ueda T; Naka N; Araki N; Hashimoto N; Myoui A; Ozaki T; Nakayama T; Toguchida J; Tanaka K; Iwamoto Y; Matsumine A; Uchida A; Ieguchi M; Kaya M; Wada T; Baba I; Kudawara I; Aoki Y; Yoshikawa H
    Oncol Rep; 2008 Feb; 19(2):467-76. PubMed ID: 18202796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic impact of SYT-SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trials.
    Stegmaier S; Leuschner I; Poremba C; Ladenstein R; Kazanowska B; Ljungman G; Scheer M; Blank B; Bielack S; Klingebiel T; Koscielniak E
    Pediatr Blood Cancer; 2017 Jan; 64(1):89-95. PubMed ID: 27621063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SYT-SSX fusion genes in synovial sarcoma of the thorax.
    Yano M; Toyooka S; Tsukuda K; Dote H; Morimoto Y; Ohata N; Ichimura K; Aoe M; Date H; Shimizu N
    Lung Cancer; 2004 Jun; 44(3):391-7. PubMed ID: 15140553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.
    Guillou L; Benhattar J; Bonichon F; Gallagher G; Terrier P; Stauffer E; Somerhausen Nde S; Michels JJ; Jundt G; Vince DR; Taylor S; Genevay M; Collin F; Trassard M; Coindre JM
    J Clin Oncol; 2004 Oct; 22(20):4040-50. PubMed ID: 15364967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel fluorescent ligase detection reaction and flow cytometric analysis of SYT-SSX fusions in synovial sarcoma.
    Gaffney R; Chakerian A; O'Connell JX; Mathers J; Garner K; Joste N; Viswanatha DS
    J Mol Diagn; 2003 May; 5(2):127-35. PubMed ID: 12707378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases.
    Coindre JM; Pelmus M; Hostein I; Lussan C; Bui BN; Guillou L
    Cancer; 2003 Dec; 98(12):2700-7. PubMed ID: 14669292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are there geographical differences in the frequency of SYT-SSX1 and SYT-SSX2 chimeric transcripts in synovial sarcoma?
    Koković I; Bracko M; Golouh R; Ligtenberg M; van Krieken HJ; Hudler P; Komel R
    Cancer Detect Prev; 2004; 28(4):294-301. PubMed ID: 15350633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript.
    Fligman I; Lonardo F; Jhanwar SC; Gerald WL; Woodruff J; Ladanyi M
    Am J Pathol; 1995 Dec; 147(6):1592-9. PubMed ID: 7495284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma.
    Inagaki H; Nagasaka T; Otsuka T; Sugiura E; Nakashima N; Eimoto T
    Mod Pathol; 2000 May; 13(5):482-8. PubMed ID: 10824918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the SYT-SSX fusion transcripts in formaldehyde-fixed, paraffin-embedded tissue: a reverse transcription polymerase chain reaction amplification assay useful in the diagnosis of synovial sarcoma.
    Lasota J; Jasinski M; Debiec-Rychter M; Szadowska A; Limon J; Miettinen M
    Mod Pathol; 1998 Jul; 11(7):626-33. PubMed ID: 9688183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.
    ten Heuvel SE; Hoekstra HJ; Bastiaannet E; Suurmeijer AJ
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):189-95. PubMed ID: 18997619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of SYT-SSX rearrangements in synovial sarcomas by real-time one-step RT-PCR.
    Nikiforova MN; Groen P; Mutema G; Nikiforov YE; Witte D
    Pediatr Dev Pathol; 2005; 8(2):162-7. PubMed ID: 15747098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diagnosis of synovial sarcoma: RT-PCR detection of SYT-SSX1/2 fusion transcripts in paraffin-embedded tissue.
    Tvrdík D; Povýsil C; Svatosová J; Dundr P
    Med Sci Monit; 2005 Mar; 11(3):MT1-7. PubMed ID: 15735574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histology and grading are important prognostic factors in synovial sarcoma.
    Bianchi G; Sambri A; Righi A; Dei Tos AP; Picci P; Donati D
    Eur J Surg Oncol; 2017 Sep; 43(9):1733-1739. PubMed ID: 28579008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.